barcelona . spain - European Association for the Study of the Liver
barcelona . spain - European Association for the Study of the Liver
barcelona . spain - European Association for the Study of the Liver
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
BARCELONA . SPAIN<br />
96 POSTGRADUATE COURSE SYLLABUS ALCOHOLIC LIVER DISEASE 97<br />
APRIL 18 - 19/2012 THE INTERNATIONAL LIVER CONGRESS TM 2012<br />
Figure 2: Metabolism <strong>of</strong> Chlordiazepoxide, Diazepam and Lorazepam.<br />
Figure 3: The Glasgow Modified Alcohol Withdrawal Score (GMAWS)<br />
Tremor<br />
0) No tremor<br />
1) On movement<br />
2) At rest<br />
Sweating<br />
0) No sweat visible<br />
1) Moist<br />
2) Drenching sweats<br />
Hallucination<br />
0) Not present<br />
1) Dissuadable<br />
2) Not dissuadable<br />
Orientation<br />
0) Orientated<br />
1) Vague, detatched<br />
2) Disorientated, no<br />
contact<br />
Agitation<br />
0) Calm<br />
1) Anxious<br />
2) Panicky<br />
Score<br />
Treatment<br />
Score: (Do not use scoring tool if patient intoxicated,<br />
must be at least 8 hours since last drink.)<br />
0: Repeat Score in 2 hours (Discontinue<br />
after scoring on 4 consecutive occasions,<br />
except if less than 48hrs after last drink)<br />
1 – 3: Give 10mg Diazepam:<br />
Repeat Score in 2 hours<br />
4 – 8: Give 20mg Diazepam:<br />
Repeat Score in 1 hour<br />
9 - 10: Give 20mg Diazepam:<br />
Repeat Score in 1 hour;<br />
discuss with medical staff<br />
REFERENCES<br />
McKeon A, Frye MA, Delanty N. The alcohol withdrawal syndrome. J Neurology<br />
Neurosurgery Psychiatry 2008; 79:854-62.<br />
Barri E, Tome S, Rodriguez I, Gude F, Sanchez-Leira J, Perez-Bacerra E,<br />
Gonzalez-Quintela A. <strong>Liver</strong> disease in heavy drinkers with and without alcohol withdrawal<br />
syndrome. Alcoholism: Clinical Experimental Research 2004; 28: 131-136.<br />
Peppers MP. Benzodiazepines <strong>for</strong> alcohol withdrawal in <strong>the</strong> elderly and in patients<br />
with liver disease. Pharmaco<strong>the</strong>rapy 1996; 16: 49-57.<br />
Hecksel KA, Bostwick JM, Jaeger TM, Cha SS. Inappropriate use <strong>of</strong> symptom-triggered<br />
<strong>the</strong>rapy <strong>for</strong> alcohol withdrawal in <strong>the</strong> general hospital. Mayo Clinic Proceedings 2008; 83: 274-279.<br />
Lejoyeux M, Solomon J, Ades J. Benzodiaepine treatment <strong>for</strong> alcohol-dependent patients. Alcohol<br />
Alcoholism 1998; 33: 563-575.<br />
Amato L, MMinozzi S, Davoli M. Efficacy and safety <strong>of</strong> pharmacological interventions<br />
<strong>for</strong> <strong>the</strong> treatment <strong>of</strong> alcohol withdrawal syndrome. Cochrane Database <strong>of</strong> Systematic<br />
Reviews 2011; 6: CD008537.pub2. DOI:10.1002/14651858<br />
Doleman JM, Hawkes ND. Combining <strong>the</strong> AUDIT questionnaire and biochemical markers<br />
to assess alcohol use and risk <strong>of</strong> alcohol withdrawal in medical patients. Alcohol Alcoholism<br />
2005; 40: 515-519.<br />
Cameron A, Morris JM, Forrest EH. The Prevalence <strong>of</strong> alcohol misuse among acute<br />
admissions: current experience and historical comparisons. Scottish Medical Journal 2006;<br />
51: 21-23.<br />
Rogawski MA. Update on <strong>the</strong> neurobiology <strong>of</strong> alcohol withdrawal seizures.<br />
Epilepsy Currents 2005; 5: 225-230.